Text

Purpose: To report a case of “hyper-responsive” resolution of exudative retinal detachment (ERD) in a patient where systemic comorbidities significantly complicated the standard of care.

Methods: Clinical examination, laboratory testing, orbital/brain MRI, and multimodal retinal imaging.

Case description: A 29-year-old female (BMI >50) presented with subacute pain, redness and loss of vision in her right eye. She was scheduled to start GLP-1 therapy. Examination revealed a progressive, circular ERD involving the macula. MRI confirmed posterior scleritis and excluded orbital and intracranial pathology. Laboratory evaluation showed significant systemic inflammation (highly elevated ESR and CRP) and metabolic derangement (A1c 11.1%, glycaemia 319 mg/dL).

Systemic treatment faced significant resistance due to risks of glycemic decompensation in the setting of morbid obesity. Following intensive multidisciplinary coordination, the patient was initiated on an insulin “bridge” alongside a conservative dose of 60 mg oral Prednisone daily (~0.4 mg/kg). Despite the sub-therapeutic weight-based dosage, complete anatomical resolution of the ERD and subfoveal fluid was documented via OCT within five days. Visual acuity improved significantly from presentation. The patient was managed with a rapid steroid taper and proton pump inhibitors without systemic crisis.

Conclusion: This case demonstrates that “hyper-resolution” of ERD is possible even with conservative steroid dosing. Given the paucity of data on optimal dosing for high-BMI patients with uncontrolled diabetes, this emphasizes the ophthalmologist’s responsibility in navigating systemic hurdles – such as morbid obesity and uncontrolled diabetes – to deliver timely, sight-saving intervention. Early detection and aggressive care coordination are paramount when the standard of care is contraindicated by systemic health.